Vectormune® IBD product information

COMPOSITION

VECTORMUNE® IBD contains a genetically engineered Marek’s Disease virus of serotype 3 (turkey Herpesvirus or HVT) expressing Infectious Bursal Disease key protective antigens. This vaccine is presented in a frozen cell-associated form.

INDICATIONS

VECTORMUNE® IBD is recommended for use in healthy one-day-old chickens or in 18 to 19-day-old embryonated chicken eggs as an aid in the prevention of Bursal Disease caused by standard and variant strains and Marek’s Disease.

ADMINISTRATION AND DOSAGE

  • Prior to use, the vaccine must be thawed and diluted appropriately with the vaccine diluent as stated in the package insert. Immediately use the vaccine and mix occasionally to ensure uniform suspension of cells. 
  • For in ovo administration, embryos are inoculated with one full dose of vaccine (in 0.05 or 0.1 ml diluent / dose). 
  • For day-old vaccination, one-day-old chicks are subcutaneously vaccinated with one full dose of vaccine (in 0.2 ml of diluent / dose) in the back of the neck. 

STORAGE 

  • Store this vaccine in liquid nitrogen.

PACKAGED

  • 1,000; 2,000 or 4,000 dose ampules

For veterinary use only